Back to search

Article

Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian Randomization study

2019-09-27

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Studies in humans and experimental models highlight a role of interleukin-6 (IL-6) in cardiovascular disease. Indirect evidence suggests that inhibition of IL-6 signaling could lower risk of coronary artery disease. However, whether such an approach would be effective for ischemic stroke and other cardiovascular outcomes remains unknown. <h4>Methods</h4> In a genome-wide assoc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8276090d-a4f6-57c1-9b8f-121284e08b03
DOI
10.1101/19007682
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian Randomization studyDOI 10.1101/19007682
Genetic downregulation of interleukin-6 signaling and arteriolosclerotic cerebral small vessel disease: a drug target Mendelian randomization analysisSemantic proximity
IL-6R Protective Variant rs7529229 Reduces Interleukin-6 Signaling and Contributes To A Decreased Ischemic Stroke RiskSemantic proximity
IL-6R protective variant rs7529229 reduces interleukin-6 signaling and contributes to decreased ischemic stroke riskSemantic proximity
Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.Semantic proximity
Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R.Semantic proximity
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosisSemantic proximity
Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study.Semantic proximity
The interplay between cytokines and stroke: a bi-directional Mendelian randomization study.Semantic proximity
Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk.Semantic proximity
Circulating interleukin-6 levels and incident ischemic stroke: a systematic review and meta-analysis of population-based cohort studiesSemantic proximity
Additive Effects of Genetic Interleukin‐6 Signaling Downregulation and Low‐Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization AnalysisSemantic proximity
Genetically downregulated interleukin-6 signaling is associated with a favorable cardiometabolic profile: a phenome-wide association studySemantic proximity
Select a neighboring publication to make it the new centre.